Kotak Alternate Asset Managers Limited (Kotak Alts), through its Kotak Life Sciences Fund I (KLSF-I), invested Rs 40 crore, while Alkemi Growth Capital, a healthcare and consumer wellness-focused venture fund, invested Rs 25 crore, the company said in a release.

